{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:56:41Z","timestamp":1790927801991,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189726","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:10:24Z","timestamp":1790547024000},"page":"189726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cGAS-STING signaling in hepatocellular carcinoma: A spatiotemporally gated immune switch linking pro-tumorigenic immune evasion and anti-tumor therapeutic response"],"prefix":"10.1016","volume":"1881","author":[{"given":"Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189726_bb0015","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl. J. Med."},{"issue":"3\u20134","key":"10.1016\/j.bbcan.2026.189726_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000343851","article-title":"Molecular link between liver fibrosis and hepatocellular carcinoma","volume":"2","author":"Sakurai","year":"2013","journal-title":"Liver Cancer."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051274","article-title":"Immune phenotype and immune checkpoint inhibitors for the treatment of human hepatocellular carcinoma","volume":"12","author":"Nishida","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10088","key":"10.1016\/j.bbcan.2026.189726_bb0035","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189726_bb0050","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189726_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189726_bb0065","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189726_bb0075","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct Activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0080","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity"},{"issue":"6121","key":"10.1016\/j.bbcan.2026.189726_bb0085","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189726_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797858","article-title":"Attenuation of cGAS-STING signaling is mediated by a p62\/SQSTM1-dependent autophagy pathway activated by TBK1","volume":"37","author":"Prabakaran","year":"2018","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0095","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189726_bb0100","article-title":"The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70063","article-title":"STING activation in various cell types in metabolic dysfunction-associated steatotic liver disease","volume":"45","author":"Wang","year":"2025","journal-title":"Liver Int."},{"issue":"41","key":"10.1016\/j.bbcan.2026.189726_bb0110","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.bbcan.2026.189726_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2017.09.010","article-title":"Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease","volume":"81","author":"Qiao","year":"2017","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189726_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj2102","article-title":"IRF3 activates RB to authorize cGAS-STING-induced senescence and mitigate liver fibrosis","volume":"10","author":"Wu","year":"2024","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189726_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2024.09.026","article-title":"Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma","volume":"84","author":"Nishimura","year":"2024","journal-title":"Mol. Cell."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189726_bb0130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189726_bb0135","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.celrep.2017.11.061","article-title":"Trafficking-mediated STING degradation requires sorting to acidified endolysosomes and can be targeted to enhance anti-tumor response","volume":"21","author":"Gonugunta","year":"2017","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41556-023-01098-9","article-title":"STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes","volume":"25","author":"Kuchitsu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189726_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.chom.2014.01.009","article-title":"Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses","volume":"15","author":"Liang","year":"2014","journal-title":"Cell Host Microbe."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0150","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2013.09.049","article-title":"Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling","volume":"155","author":"Konno","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004783","article-title":"PPM1A regulates antiviral signaling by antagonizing TBK1-mediated STING phosphorylation and aggregation","volume":"11","author":"Li","year":"2015","journal-title":"PLoS Pathog."},{"issue":"7976","key":"10.1016\/j.bbcan.2026.189726_bb0160","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0170","first-page":"45","article-title":"Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189726_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0180","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0190","article-title":"TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling","volume":"5","author":"Su","year":"2023","journal-title":"JHEP Rep."},{"issue":"50","key":"10.1016\/j.bbcan.2026.189726_bb0195","doi-asserted-by":"crossref","first-page":"32005","DOI":"10.1073\/pnas.2015343117","article-title":"Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells","volume":"117","author":"Eisinger","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189726_bb0200","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162139","article-title":"PP2Ac\/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages","volume":"133","author":"Ho","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189726_bb0205","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/thno.37745","article-title":"Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells","volume":"10","author":"Miao","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189726_bb0210","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220759","article-title":"Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS\/STING\/IFN-mediated nucleic acid sensing","volume":"219","author":"Kessler","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189726_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2024.01.048","article-title":"STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment","volume":"369","author":"Ao","year":"2024","journal-title":"J. Control Release"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189726_bb0220","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/cas.70172","article-title":"Mitochondrial DNA-mediated intercellular communication via extracellular vesicles under hypoxic stress to drive HCC progression","volume":"116","author":"Fu","year":"2025","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189726_bb0225","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1478-3231.2006.01342.x","article-title":"Role of Kupffer cells in host defense and liver disease","volume":"26","author":"Bilzer","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.bbcan.2026.189726_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102367","article-title":"STING signaling sensing of DRP1-dependent mtDNA release in kupffer cells contributes to lipopolysaccharide-induced liver injury in mice","volume":"54","author":"Zhang","year":"2022","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189726_bb0235","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41388-019-1108-8","article-title":"The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma","volume":"39","author":"Thomsen","year":"2020","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189726_bb0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189726_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1199519","article-title":"Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions","volume":"11","author":"Xu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189726_bb0250","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189726_bb0255","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0260","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0265","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0270","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189726_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197378","article-title":"Dendritic cell and T cell crosstalk in liver fibrogenesis and hepatocarcinogenesis: implications for prevention and therapy of liver cancer","volume":"21","author":"Lurje","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189726_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114318","article-title":"Co-delivery of SN38 and MEF2D-siRNA via tLyp-1-modified liposomes reverses PD-L1 expression induced by STING activation in hepatocellular carcinoma","volume":"245","author":"Du","year":"2025","journal-title":"Colloids Surf B Biointerfaces."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189726_bb0285","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2022.03.011","article-title":"Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model","volume":"77","author":"Wang","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215880","article-title":"Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity","volume":"547","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"issue":"49","key":"10.1016\/j.bbcan.2026.189726_bb0295","article-title":"ZnS@BSA nanoclusters potentiate efficacy of cancer immunotherapy","volume":"33","author":"Cen","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189726_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101404","article-title":"cGAS-STING signalings potentiate tumor progression via sustaining cancer stemness","volume":"20","author":"Liu","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121856","article-title":"Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy","volume":"290","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0310","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12967-025-06843-2","article-title":"The cGAS-STING pathway: a dual regulator of immune response in cancer and therapeutic implications","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0315","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/s41467-021-22572-8","article-title":"STING enhances cell death through regulation of reactive oxygen species and DNA damage","volume":"12","author":"Hayman","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0320","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.immuni.2018.10.001","article-title":"Tumor cGAMP awakens the natural killers","volume":"49","author":"Sundararaman","year":"2018","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189726_bb0325","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41422-022-00731-w","article-title":"Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity","volume":"32","author":"Gao","year":"2022","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0330","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.28685","article-title":"Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection","volume":"64","author":"Thomsen","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-023-43743-9","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nat. Commun."},{"issue":"52","key":"10.1016\/j.bbcan.2026.189726_bb0340","doi-asserted-by":"crossref","first-page":"26794","DOI":"10.1074\/jbc.M116.736991","article-title":"Endoplasmic reticulum stress-induced hepatocellular death pathways mediate liver injury and fibrosis via stimulator of interferon genes","volume":"291","author":"Iracheta-Vellve","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0345","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12964-023-01114-3","article-title":"IL-33\/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunity","volume":"21","author":"Wang","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbcan.2026.189726_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217183","article-title":"Reuterin promotes pyroptosis in hepatocellular cancer cells through mtDNA-mediated STING activation and caspase 8 expression","volume":"601","author":"Cui","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189726_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122766","article-title":"Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy","volume":"313","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189726_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004006","article-title":"Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC","volume":"10","author":"Li","year":"2022","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.bbcan.2026.189726_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111628","article-title":"Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma","volume":"129","author":"Xu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0370","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/HEP.0000000000000388","article-title":"Mitochondrial DNA and the STING pathway are required for hepatic stellate cell activation","volume":"78","author":"Arumugam","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2026.189726_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114653","article-title":"Oroxylin A activates ferritinophagy to induce hepatic stellate cell senescence against hepatic fibrosis by regulating cGAS-STING pathway","volume":"162","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189726_bb0380","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Pt B","key":"10.1016\/j.bbcan.2026.189726_bb0385","article-title":"Activation of cGAS-STING signaling pathway promotes liver fibrosis and hepatic sinusoidal microthrombosis","volume":"125","author":"Luo","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0390","doi-asserted-by":"crossref","DOI":"10.1172\/JCI207031","article-title":"Metabolic stress-activated endothelial STING rewires the sinusoidal immune niche in MASLD","author":"Lin","year":"2026","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189726_bb0395","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1172\/JCI125413","article-title":"STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade","volume":"129","author":"Yang","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0400","doi-asserted-by":"crossref","first-page":"91","DOI":"10.14218\/JCTH.2023.00197","article-title":"Update on the STING signaling pathway in developing nonalcoholic fatty liver disease","volume":"12","author":"Liu","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0405","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/med.21649","article-title":"Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy","volume":"40","author":"Wu","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0410","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation Trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, Phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189726_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010511","article-title":"Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors","volume":"13","author":"Luke","year":"2025","journal-title":"J. Immunother Cancer."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189726_bb0425","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","article-title":"Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Harrington","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"8_Supplement_2","key":"10.1016\/j.bbcan.2026.189726_bb0430","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-LB397","article-title":"Abstract LB397: Biomarker-guided dose selection in the iintune-1 study of dazostinag,a STING agonist, alone and in combination with pembrolizumab for patients with metastatic solid tumors","volume":"85","author":"Ramesh","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40364-025-00820-z","article-title":"Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging","volume":"13","author":"Quan","year":"2025","journal-title":"Biomark Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0440","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1038\/s41467-025-66581-3","article-title":"Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0445","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl. J. Med."},{"issue":"10126","key":"10.1016\/j.bbcan.2026.189726_bb0450","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0455","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0460","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-025-03632-z","article-title":"Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma","volume":"45","author":"Rider","year":"2026","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0465","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Management of hepatocellular carcinoma","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111769","article-title":"Radiofrequency hyperthermia enhances the effect of OK-432 for Hepatocellular carcinoma by activating of TLR4-cGAS-STING pathway","volume":"130","author":"Sun","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189726_bb0475","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1021\/acsnano.3c08064","article-title":"A booster for radiofrequency ablation: advanced adjuvant therapy via in situ nanovaccine synergized with anti-programmed death ligand 1 immunotherapy for systemically constraining hepatocellular carcinoma","volume":"17","author":"Tian","year":"2023","journal-title":"ACS Nano."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0480","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-025-07622-z","article-title":"Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma","volume":"16","author":"Sun","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189726_bb0485","first-page":"1096","article-title":"Transarterial chemoembolization modulates the exosomal miR-32-5p\/cGAS-STING axis mediated macrophage ferroptosis, triggers immune remodeling, and enhances anti-PD-1\/L1 Efficacy in HCC","volume":"9","author":"Tang","year":"2026","journal-title":"Research (Wash D C)."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189726_bb0490","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202500857","article-title":"Mineralized supramolecular microspheres with immunoregulating functions for transarterial chemoembolization immunotherapy of hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2025","journal-title":"Small Methods."},{"issue":"43","key":"10.1016\/j.bbcan.2026.189726_bb0495","article-title":"Lactate-modulating nanoreactors facilitate self-amplifying pyroptosis and the cGAS-STING cascade for potentiated catalytic-immunotherapy","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bbcan.2026.189726_bb0500","article-title":"Combination of irinotecan silicasome nanoparticles with radiation therapy sensitizes immunotherapy by modulating the activation of the cGAS\/STING pathway for colorectal cancer","volume":"23","author":"Wang","year":"2023","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.bbcan.2026.189726_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1525083","article-title":"IFN\u03bb1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer","volume":"15","author":"Godsk","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0510","article-title":"Targeting redox metabolism and low-dose radiotherapy synergistically activate cGAS-STING pathway to improve NK cell therapy efficacy in hepatocellular carcinoma","volume":"24","author":"Liu","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189726_bb0515","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170532","article-title":"Cell cycle inhibitors activate the hypoxia-induced DDX41\/STING pathway to mediate antitumor immune response in liver cancer","volume":"9","author":"Wong","year":"2024","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0520","first-page":"396","article-title":"Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p\/STING axis","volume":"22","author":"Yuan","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189726_bb0525","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf286","article-title":"First-line atezolizumab\/bevacizumab or durvalumab\/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study","volume":"30","author":"Kournoutas","year":"2025","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0530","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0535","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2147\/JHC.S347932","article-title":"Safety and efficacy of atezolizumab and bevacizumab combination as a first line treatment of advanced hepatocellular carcinoma","volume":"10","author":"Zanuso","year":"2023","journal-title":"J. Hepatocell Carcinoma."},{"key":"10.1016\/j.bbcan.2026.189726_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189726_bb0545","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI86892","article-title":"The host STING pathway at the interface of cancer and immunity","volume":"126","author":"Corrales","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189726_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178649","article-title":"A study on the efficacy and pharmacological mechanism of liposome complexes containing STING agonist and anti-PD-L1 nanobody in inhibiting HCC","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol Sci."},{"key":"10.1016\/j.bbcan.2026.189726_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216568","article-title":"Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway","volume":"582","author":"Ding","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0560","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41419-024-06685-8","article-title":"Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0565","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189726_bb0570","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011572","article-title":"Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies","volume":"13","author":"Jacoby","year":"2025","journal-title":"J. Immunother Cancer."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0575","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41467-023-37217-1","article-title":"Epigenetic state determines the in vivo efficacy of STING agonist therapy","volume":"14","author":"Falahat","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0580","article-title":"Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy","volume":"7","author":"Shi","year":"2025","journal-title":"Innovation (Camb)."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0585","article-title":"Leveraging the crosstalk between cGAS-STING and pyroptosis by nanomedicine to enhance antitumor immunity","volume":"24","author":"Wang","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"51","key":"10.1016\/j.bbcan.2026.189726_bb0590","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305255","article-title":"Elucidation of protonation cooperativity of a STING-activating polymer","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0595","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-025-03520-6","article-title":"Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189726_bb0600","article-title":"A DNA\/DMXAA\/metal-organic framework activator of innate immunity for boosting anticancer immunity","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"issue":"32","key":"10.1016\/j.bbcan.2026.189726_bb0605","article-title":"Laparoscopic delivery of a MnO2-P-ICG patch for photodynamic therapy and NK cell-driven immunotherapy in hepatocellular carcinoma","volume":"13","author":"Lin","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bbcan.2026.189726_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113957","article-title":"Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy","volume":"384","author":"Kong","year":"2025","journal-title":"J. Control Release."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0615","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12951-024-02354-2","article-title":"Smart responsive Fe\/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation","volume":"22","author":"Du","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189726_bb0620","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1186\/s12951-025-03870-5","article-title":"A novel biomimetic nanoplatform amplifies ferroptosis for specific cGAS-STING pathway activation to enhance hepatocellular carcinoma chemo-immunotherapy","volume":"23","author":"Peng","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0625","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","article-title":"Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications","volume":"144","author":"Mohammadpour","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189726_bb0630","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/acs.jmedchem.3c01785","article-title":"Simultaneous activation of immunogenic cell death and cGAS-STING pathway by liver- and mitochondria-targeted Gold(I) complexes for chemoimmunotherapy of hepatocellular carcinoma","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"issue":"31","key":"10.1016\/j.bbcan.2026.189726_bb0635","article-title":"Smartly assembled near-micron rf-responsive agents bridge transarterial embolization and immunothermal potentiation","volume":"13","author":"Hu","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189726_bb0640","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189726_bb0645","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/17425247.2024.2375400","article-title":"Understanding nanoparticle-liver interactions in nanomedicine","volume":"21","author":"He","year":"2024","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.bbcan.2026.189726_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2017.03.001","article-title":"Complement activation turnover on surfaces of nanoparticles","volume":"15","author":"Moghimi","year":"2017","journal-title":"Nano Today."},{"key":"10.1016\/j.bbcan.2026.189726_bb0655","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbcan.2026.189726_bb0660","article-title":"Mechanisms of immune response to inorganic nanoparticles and their degradation products","volume":"180","author":"Mohammapdour","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189726_bb0665","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189726_bb0670","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189726_bb0675","first-page":"1423","article-title":"Harnessing the STING pathway for HCC treatment","volume":"22","author":"Wong","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189726_bb0680","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s41401-023-01220-5","article-title":"The dual function of cGAS-STING signaling axis in liver diseases","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbcan.2026.189726_bb0685","article-title":"Targeting cGAS-STING: modulating the immune landscape of hepatic diseases","volume":"16","author":"Xue","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189726_bb0690","first-page":"48","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies","volume":"8","author":"Chen","year":"2025","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bbcan.2026.189726_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2026.108991","article-title":"Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance","volume":"280","author":"Wang","year":"2026","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189726_bb0700","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","article-title":"Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production","volume":"37","author":"Konno","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189726_bb0705","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.omtn.2018.11.003","article-title":"An analysis of the expression and association with immune cell infiltration of the cGAS\/STING pathway in pan-cancer","volume":"14","author":"An","year":"2018","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.bbcan.2026.189726_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102691","article-title":"cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases","volume":"105","author":"Wang","year":"2025","journal-title":"Ageing Res. Rev."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:41:20Z","timestamp":1790926880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":142,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26001988"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189726","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cGAS-STING signaling in hepatocellular carcinoma: A spatiotemporally gated immune switch linking pro-tumorigenic immune evasion and anti-tumor therapeutic response","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189726"}}